BGPT: Author Review: Jason Yim

Fuel Your Discoveries

Quick Explanation Copied

Author Review — Jason Yim (brief)

Jason Yim is an active contributor in generative models for proteins and biomedical AI, co-authoring several high-impact papers (including a Nature-design protein design paper and a Nature Medicine clinical-AI study), and multiple diffusion/diffusion-like protein-structure preprints; his role is often as a middle/co-author on collaborative interdisciplinary teams

See the full visual review below (graphs, strengths, gaps, and suggested next steps).

Long Explanation

Author Review — Jason Yim (detailed, visual)

1) Publication impact over time (raw counts)

Note: the plotted values are per-year cited-by counts from aggregated metadata (OpenAlex counts_by_year) associated with an author profile; the log scale highlights spikes driven by a few highly-cited co-authored works (see citations below).

2) Representative high-impact works (selected, with extracts)

RFdiffusion — protein design (Nature 2023) — coauthorship demonstrates contributions to state-of-the-art generative protein design; peer-reviewed, broad methods and evaluation
Predicting conversion to wet AMD (Nature Medicine 2020) — first-author clinical-AI study applying deep learning to OCT imaging with translational focus
SE(3) diffusion model — backbone generation (arXiv 2023) — preprint advancing diffusion models over 3D rigid frames for protein backbone generation
Review: Diffusion models in protein structure and docking (WCMS 2024) — synthesis/review indicating expertise in the diffusion-methods landscape for structural biology

3) Strengths, gaps, and scientific evaluation

Strengths — Demonstrated capacity to contribute to both methodological machine-learning advances (SE(3)/diffusion models) and translational clinical-AI work (AMD prediction). Coauthorship on high-impact, peer-reviewed protein-design work (Nature) and a clinical AI paper (Nature Medicine) signals strong collaborative positioning and technical competence in ML for biology

Gaps & potential blindspots — Primary-author methodological papers appear as preprints or conference-level; several high-impact citations stem from large-team papers where Yim is a middle author, so individual contribution magnitude is unclear from metadata alone; institutional affiliations are variable across metadata snapshots (DeepMind / MIT / University of Washington appear in different items), which complicates judgment of research independence and leadership. The field (generative protein models) is rapidly moving — reproducibility, experimental validation of designed proteins, and ablation studies remain essential and sometimes underreported in preprints

Risks of over-interpretation — High team-citation counts can inflate apparent individual impact (team-author effect); independent reproducible demonstrations and first/last author roles better indicate leadership. Also, preprints’ claims should be weighted lower than peer-reviewed validations when assessing scientific certainty.

4) Concrete recommendations to strengthen scientific profile

Publish more first/last-author peer-reviewed methodological or experimental validations (especially in protein design) to document independent contributions and reproducibility.
Include explicit author contribution statements and release code/data for key methodological papers to improve reproducibility and credit assignment.
Perform ablation and wet-lab validation (for protein design claims) where feasible, or partner closely with experimental groups and make those links explicit in manuscripts.
Consolidate and publicize a stable author profile (ORCID is present) and institutional affiliation(s) on major records (OpenAlex/ORCID/Google Scholar) to reduce metadata fragmentation.

5) Next-science actions (one-click)

Run BGPT's Science AI agent to automatically aggregate all raw-data supplements, code repos, and experimental validation for Jason Yim's authored works (preprints + peer-reviewed) and produce a reproducibility checklist and authorship-contribution map.

Feedback:

Updated: January 31, 2026